HCPLive
MARCH 24, 2025
Veeral Sheth, MD, is joined by the CEO of Neurotech to discuss the historic approval of revakinagene taroretcel (ENCELTO) for macular telangiectasia type 2.
Journal of Cardiovascular Electrophysiology
MARCH 24, 2025
ABSTRACT Sudden cardiac death (SCD) is a major public health challenge, resulting in significant loss of life each year. Effective prevention relies on identifying individuals at elevated risk; however, accurate prediction of SCD has proven difficult. The current clinical strategy relies on a static risk assessment, primarily using left ventricular ejection fraction (LVEF)<35% as a key criterion.
HCPLive
MARCH 24, 2025
Analgesic effects lasted up to week 8 while function improvements lasted until week 16 in a new randomized, controlled trial.
DAIC
MARCH 24, 2025
tim.hodson Mon, 03/24/2025 - 15:48 March 24, 2025 Imperative Care, Inc. recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the 82 cm version of its Symphony 16F catheter. The catheter is designed to elevate care for patients with venous thrombosis, a serious condition caused by a blood clot forming in the veins of the legs or abdomen that can have a life-threatening impact if left untreated.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
HCPLive
MARCH 24, 2025
A study found that genetics and environment both influence allergy risk, but environmental factors play a stronger role in the progression of allergic disease.
American Heart News - Heart News
MARCH 24, 2025
DALLAS, March 24, 2025 Globally, the rate of death from chronic kidney disease increased 24% from 1990 to 2021, according to statistics published by the American Heart Association, a global force changing the future of health for all. The rise in.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HeartRhythm
MARCH 24, 2025
Focal coronary spasm is a recognised complication of pulsed field ablation (PFA) delivered within proximity of coronary arteries (1). There have been 2 recent case reports of focal spasm occurring during pulmonary vein isolation (PVI) for atrial fibrillation (AF) using PFA remote from coronary arteries (2,3). Our centre is a high volume PFA unit for AF ablation in the UK (47).
American College of Cardiology
MARCH 24, 2025
Among individuals without significant cardiovascular morbidity younger than 50 years, the use of cannabis is linked to adverse cardiovascular events, including a sixfold higher risk of a myocardial infarction (MI), fourfold increase risk of ischemic stroke.
Medical Xpress - Cardiology
MARCH 24, 2025
Globally, the rate of death from chronic kidney disease increased 24% from 1990 to 2021, according to statistics published by the American Heart Association. The rise in kidney disease rates is a major concern for cardiovascular health around the world. Kidney disease increases heart disease risk, yet as many as 9 in 10 U.S. adults with chronic kidney disease do not know they have it.
HeartRhythm
MARCH 24, 2025
Atrial flutter (AFL) and atrial fibrillation (AF) are believed to carry the same risk of systemic thromboembolism however there is paucity of data concerning such risk in patients with AFL in comparison to AF.
HCPLive
MARCH 24, 2025
Goel explains the importance of second-line therapies and describes the role PPARs play in PBC treatment, including 2 newly approved therapies.
American College of Cardiology
MARCH 24, 2025
In older adults, an acute respiratory syncytial virus (RSV) infection was significantly associated with an increased risk of cardiovascular events, in particular ischemic stroke and heart failure (HF) hospitalization.
HCPLive
MARCH 24, 2025
These data highlight the long-term maintenance of bimekizumab responses among individuals with psoriasis, looking at bio-nave and bio-switched patients.
Journal of Cardiothoracic Surgery
MARCH 24, 2025
The objective was to assess the clinical efficacy of long non-coding RNA (lncRNA) alpha-2-macroglobulin-antisense 1 (A2M-AS1) in acute myocardial infarction (AMI).
HCPLive
MARCH 24, 2025
A new study found that the time it takes to diagnose alpha-gal syndrome has improved from 5.3 years to 28 days since 2011, but disparities remain based on education level.
Journal of Cardiothoracic Surgery
MARCH 24, 2025
This study compares sleep duration and stroke risk between residents of China and the U.S. during and outside the COVID-19 pandemic, examining age as an interaction effect.
HCPLive
MARCH 24, 2025
Schilsky describes lingering challenges and unmet needs in Wilson disease and highlights recent innovations in monitoring and diagnosis.
Med Page Today
MARCH 24, 2025
(MedPage Today) -- With radial artery (RA) grafts still underutilized in coronary artery bypass grafting (CABG) surgery, at least one barrier to this surgical approach may be addressed with medication, a pilot trial suggested. Testing the effects.
HCPLive
MARCH 24, 2025
Khandelwal discusses advancements in intraocular lens (IOL) categories and the patient's role in choosing more innovative options.
Medical Xpress - Cardiology
MARCH 24, 2025
A recent study from National Taiwan University Hospital shows that apixaban, a blood-thinning medication, can help prevent blood clots in dialysis patients after a procedure to clear blocked vascular access. Dialysis patients rely on vascular accesslike fistulas or graftsto filter their blood, but clots can form and block these pathways, making dialysis impossible.
HCPLive
MARCH 24, 2025
In this analysis, French investigators highlight patient and clinician perspectives on 1-year use of tildrakizumab for moderate-to-severe psoriasis.
American College of Cardiology
MARCH 24, 2025
In U.S. adults 80 years and older taking antihypertensive agents for systolic blood pressure (SBP), intensive SBP control is associated with a reduced risk of death from cardiovascular disease, supporting guidelines for intensive BP control.
HCPLive
MARCH 24, 2025
Repka dives into the role of advocacy in shaping ophthalmologic policies and ensuring equitable patient care.
Medical Xpress - Cardiology
MARCH 24, 2025
Living in a disadvantaged neighborhood contributes to a rare form of heart failure known as peripartum cardiomyopathy, a potentially deadly disease that disproportionately affects Black mothers.
HCPLive
MARCH 24, 2025
Repka describes the complications of the US healthcare system and how to advance interactions in advocacy efforts.
HeartRhythm
MARCH 24, 2025
Trans-right atrial appendage (RAA) pericardial insufflation of CO2 can improve safety of percutaneous epicardial access. Dedicated device solutions for safe, effective and standardized microperforation are needed.
HCPLive
MARCH 24, 2025
Lammert describes the clinical impact of having 2 new second-line PBC therapies, challenges to their uptake, and areas where more research is needed.
Medical Xpress - Cardiology
MARCH 24, 2025
The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of people.
HCPLive
MARCH 24, 2025
Panelists discuss how Janus kinase (JAK) inhibitors such as upadacitinib, abrocitinib, and baricitinib offer rapid, oral treatment for moderate to severe atopic dermatitis, differing from injectable biologics in administration, broader immunosuppression, and risk of adverse events like thromboembolism. They provide effective symptom control but require safety monitoring.
Medical Xpress - Cardiology
MARCH 24, 2025
Atherosclerosis (AS) is a chronic inflammatory disease characterized by the buildup of lipids and immune cells in arterial walls, increasing the risk of cardiovascular conditions. While multiple factors contribute to AS, recent research highlights the role of copper, an essential trace element, in disease progression.
HCPLive
MARCH 24, 2025
Panelists discuss how the Measure Up 1 and 2 studies (Simpson 2022) showed that at 52 weeks, 82.0% to 84.9% of upadacitinib patients achieved EASI-75. Common adverse effects (AEs) included acne, cough, and headache, with 4.5% to 7.2% withdrawal rates.
HeartRhythm
MARCH 24, 2025
Little is known about the risk factors and prognosis of new-onset atrial fibrillation (NOAF) in patients with primary percutaneous coronary intervention (PCI).
Stroke Journal
MARCH 24, 2025
Stroke, Ahead of Print. BACKGROUND:A novel genetic cerebral small vessel disease, linked to the insertion of a mobile genetic element in theCOL4A1gene has recently been identified. Notably, 8 out of the 10 families carrying this mutation were known to come from Brittany, a specific region in France, suggesting the possibility of a common ancestor and a founder effect.METHODS:Probands from each of the 10 families were analyzed with high-density SNP arrays.
HeartRhythm
MARCH 24, 2025
Atrial fibrillation (AF) confers significant morbidity and mortality in the form of embolic stroke, heart failure, cognitive decline, and recurrent hospitalizations as well as health care costs.1 This risk of stroke can be reduced with oral anticoagulation, but despite this, there exists a significant risk of residual major adverse events, highlighting the need for a more comprehensive approach.
Stroke Journal
MARCH 24, 2025
Stroke, Ahead of Print. BACKGROUND:The modified Rankin Scale (mRS) is a key measure of functional outcomes in stroke trials. To minimize variability, structured tools like the Rankin Focused Assessment and central adjudication are recommended. This study compares local versus centrally adjudicated mRS scores in the MOST trial (Multi-Arm Optimization of Stroke Thrombolysis).METHODS:MOST was a phase 3, single-blind, randomized trial evaluating argatroban, eptifibatide, or placebo in addition to in
HeartRhythm
MARCH 24, 2025
Quadripolar coronary sinus (CS) leads are commonly employed to achieve left ventricular pacing. There are limited data on extraction of these leads relative to traditional unipolar or bipolar CS pacing leads.
Expert insights. Personalized for you.
110 
Let's personalize your content